GRIA1 and skin basal cell carcinoma: Notably, BCC treatment appears to regulate pGluA1-S845 in a biphasic manner (Fig. 2B), similar to the biphasic network responses observed on MEA recordings (Fig. 4C) consistent with GluA1-S845 dephosphorylation being a component of scaling expression rather than induction.